Jiang Y, Xu C, He W, Zhang C, et al. First-line therapies analysis in advanced/metastatic urothelial carcinoma: prognostic insights in ADCs combined therapy with propensity score analysis and RNA-Seq. Int Immunopharmacol 2026;169:116060.
PMID: 41411730